research microscope image

Research Programs

The Leukemia & Lymphoma Society of Canada's (LLSC's) research programs, along with the US (LLS), are creating tomorrow's treatments and laying the groundwork for the ultimate cures. We fund research across the continuum, from basic research through clinical trials, from bench to bedside. To date, we have invested more than $1 billion in research to advance therapies and save lives. Research grants have funded many of today's most promising advances, including targeted therapies and immunotherapies and some of the therapies first approved for blood cancer patients are now helping patients with other types of cancers and other serious diseases.

Thanks to research and access to better treatments, survival rates for many blood cancer patients have doubled, tripled and even quadrupled since 1960.

Donate Today      

 

Grants

lab test tube image

Academic Grants

The Leukemia & Lymphoma Society of Canada's (LLSC's) academic grants support and encourage basic and translational leukemia, lymphoma, Hodgkin's disease and myeloma research. LLSC investigators are outstanding scientists at the forefront of leukemia, lymphoma, Hodgkin's disease and myeloma research at centres throughout Canada. We award academic grants for studies that range from basic blood cancer resear...

research image for operating grants

Operating Grants

DEADLINE FOR SUBMISSION OF LETTERS OF INTENT: Midnight EST, November 1, 2017   We are pleased to advise you that The Leukemia & Lymphoma Society of Canada (LLSC) is accepting letters of intent in the following categories: Operating Grants New Idea Award  Canadian Blood Cancer Researchers, new and established, are invited to submit letters of intent for the Leukemia & L...

New Idea Award

New Idea Award

The New Idea Award is a concept award to support innovative approaches that may fundamentally change the understanding, diagnosis and/or treatment of blood cancers and related pre-malignant conditions. This grant  program is designed to identify novel research strategies with a potential for high impact on blood cancer. Specifically, this program supports the initial exploration of untested but potentially tr...